Q1 2026 Holdings
Filed 2026-05-15 | 83 holdings | $439.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $56.5M | 580,678 | 12.8% |
| Spdr S&P Biotech ETF(XBI) | ETF | 78464A870 | $40.7M | 318,505 | 9.3% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $25.2M | 13,680,554 | 5.7% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $21.0M | 978,463 | 4.8% |
| Atricure Inc(ATRC) | COM | 04963C209 | $17.0M | 597,431 | 3.9% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $15.9M | 476,740 | 3.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $14.6M | 250,772 | 3.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $14.3M | 217,497 | 3.3% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $13.4M | 2,418,882 | 3.0% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $11.9M | 165,178 | 2.7% |
| Ishares Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $10.5M | 62,095 | 2.4% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $9.6M | 443,829 | 2.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $9.3M | 70,615 | 2.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $9.1M | 2,029,164 | 2.1% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $8.4M | 421,733 | 1.9% |
| Axogen Inc(AXGN) | COM | 05463X106 | $8.3M | 249,960 | 1.9% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $7.2M | 845,735 | 1.6% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $6.8M | 355,208 | 1.5% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $6.1M | 318,500 | 1.4% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $5.9M | $4,000,000 | 1.3% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $5.5M | 2,434,353 | 1.3% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.4M | 86,279 | 1.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.4M | 267,402 | 1.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $5.3M | 23,177 | 1.2% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $5.2M | 175,465 | 1.2% |
| Inogen Inc(INGN) | COM | 45780L104 | $5.2M | 845,179 | 1.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $5.1M | 217,355 | 1.2% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $4.9M | 139,482 | 1.1% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $4.3M | 130,875 | 1.0% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $4.1M | 430,248 | 0.9% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.9M | 130,175 | 0.9% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $3.7M | 150,524 | 0.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $3.5M | 112,236 | 0.8% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $3.5M | 171,006 | 0.8% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $3.3M | 1,370,118 | 0.8% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $3.0M | 120,000 | 0.7% |
| Align Technology Inc(ALGN) | COM | 016255101 | $2.6M | 15,000 | 0.6% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $2.5M | 1,567,561 | 0.6% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $2.4M | 498,361 | 0.5% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $2.3M | 75,000 | 0.5% |
| Insulet Corp(PODD) | COM | 45784P101 | $2.3M | 10,870 | 0.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $2.2M | 46,500 | 0.5% |
| Immatics NV(IMTX) | SHS | N44445109 | $2.2M | 225,860 | 0.5% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $2.2M | 68,518 | 0.5% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $2.2M | 377,059 | 0.5% |
| Alector Inc(ALEC) | COM | 014442107 | $2.0M | 908,351 | 0.4% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $1.9M | 59,516 | 0.4% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.9M | 235,868 | 0.4% |
| Profound Medical Corp(PROF) | COM NEW | 74319B502 | $1.7M | 263,005 | 0.4% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $1.6M | 205,000 | 0.4% |